Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Clinical Features of Primary and Systemic Metastatic Intraocular Lymphomas in Spanish Patients.

Llorenç V, Fuster C, Alba-Linero C, Moll-Udina A, Serrano A, Solé M, Sainz de la Maza M, Aldecoa I, Adán A.

J Ophthalmol. 2019 Oct 16;2019:6327041. doi: 10.1155/2019/6327041. eCollection 2019.

2.

Angiography and En Face Optical Coherence Tomography Findings in Acute Syphilitic Posterior Placoid Chorioretinopathy.

Moll-Udina A, Figueroa-Vercellino JP, Llorenç V, Miguel L, Adán A.

Case Rep Ophthalmol. 2019 May 23;10(2):165-171. doi: 10.1159/000500239. eCollection 2019 May-Aug.

3.

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro.

Mesquida M, Drawnel F, Lait PJ, Copland DA, Stimpson ML, Llorenç V, Sainz de la Maza M, Adan A, Widmer G, Strassburger P, Fauser S, Dick AD, Lee RWJ, Molins B.

Transl Vis Sci Technol. 2019 Oct 28;8(5):32. doi: 10.1167/tvst.8.5.32. eCollection 2019 Sep.

4.

Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report.

Adán A, Moll-Udina A, Ramirez J, Llorenç V.

Ocul Immunol Inflamm. 2019 Oct 7:1-3. doi: 10.1080/09273948.2019.1644350. [Epub ahead of print]

PMID:
31589540
5.

Long-Term Intravitreal Dexamethasone Implant Outcomes in Uveitis.

Alba-Linero C, Sala-Puigdollers A, Romero B, Llorenç V, Adan A, Zarranz-Ventura J.

Ocul Immunol Inflamm. 2019 Apr 17:1-10. doi: 10.1080/09273948.2019.1578380. [Epub ahead of print]

PMID:
30994370
6.

Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis.

Matas J, Llorenç V, Fonollosa A, Esquinas C, Diaz-Valle D, Berasategui B, Mesquida M, Artaraz J, Rios J, Adan A.

PLoS One. 2019 Jan 24;14(1):e0210799. doi: 10.1371/journal.pone.0210799. eCollection 2019.

7.

Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.

Battaglia Parodi M, Romano F, Marchese A, Arrigo A, Llorenç V, Cicinelli MV, Bandello F, Adán A.

Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):273-278. doi: 10.1007/s00417-018-4190-7. Epub 2018 Nov 23.

PMID:
30470876
8.

Antituberculous Treatment Itself Might Prevent Visual Impairment in Presumed Tuberculosis-Related Uveitis.

Llorenç V, Benejam G, Mesquida M, Sainz de la Maza M, Molins B, Alba C, Pelegrin L, Martínez JA, Adán A.

Ocul Immunol Inflamm. 2018 Nov 5:1-8. doi: 10.1080/09273948.2018.1541326. [Epub ahead of print]

PMID:
30395738
9.

Bilateral Acute Retinal Necrosis: Clinical Features and Outcomes in a Multicenter Study.

Miserocchi E, Iuliano L, Fogliato G, Modorati G, Couto C, Schlaen A, Hurtado E, Llorenç V, Adan A, Bandello F.

Ocul Immunol Inflamm. 2019;27(7):1090-1098. doi: 10.1080/09273948.2018.1501494. Epub 2018 Jul 30.

PMID:
30059636
10.

Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study.

Berasategui B, Fonollosa A, Artaraz J, Ruiz-Arruza I, Ríos J, Matas J, Llorenç V, Diaz-Valle D, Sastre-Ibañez M, Arriola-Villalobos P, Adan A.

BMC Ophthalmol. 2018 Jul 20;18(1):179. doi: 10.1186/s12886-018-0848-5.

11.

Reply.

Mesquida M, Llorenc V, Adan A.

Med Clin (Barc). 2018 Oct 23;151(8):336-337. doi: 10.1016/j.medcli.2018.02.005. Epub 2018 Mar 7. English, Spanish. No abstract available.

PMID:
29525112
12.

Targeting interleukin-6 in autoimmune uveitis.

Mesquida M, Molins B, Llorenç V, de la Maza MS, Adán A.

Autoimmun Rev. 2017 Oct;16(10):1079-1089. doi: 10.1016/j.autrev.2017.08.002. Epub 2017 Aug 2. Review.

PMID:
28778705
13.

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.

Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Sainz de la Maza M, Adán A.

Retina. 2018 Jul;38(7):1361-1370. doi: 10.1097/IAE.0000000000001690.

PMID:
28520640
14.

Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature review.

Pelegrín L, Hernández-Rodríguez J, Espinosa G, Llorenç V, Sainz-de-la-Maza M, Fontenla JR, Martínez JA, Cid MC, Adán A.

Autoimmun Rev. 2017 Mar;16(3):237-243. doi: 10.1016/j.autrev.2017.01.006. Epub 2017 Jan 27. Review.

PMID:
28137481
15.

Bacillus Calmette-Guérin Infection and Cytotoxicity in the Retinal Pigment Epithelium.

Llorenç V, Mesquida M, Molins B, González-Martín J, Sainz de la Maza M, Adán A.

Ocul Immunol Inflamm. 2018;26(5):786-792. doi: 10.1080/09273948.2016.1265655. Epub 2016 Dec 23.

PMID:
28010156
16.

C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function.

Molins B, Pascual A, Méndez, Llorenç V, Zarranz-Ventura J, Mesquida M, Adán A, Martorell J.

Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C244-C253. doi: 10.1152/ajpcell.00057.2016. Epub 2016 Dec 21.

17.

New insights into the genetic component of non-infectious uveitis through an Immunochip strategy.

Márquez A, Cordero-Coma M, Martín-Villa JM, Gorroño-Echebarría MB, Blanco R, Díaz Valle D, Del Rio MJ, Blanco A, Olea JL, Cordero Y, Capella MJ, Díaz-Llopis M, Ortego-Centeno N, Ruiz-Arruza I, Llorenç V, Adán A, Fonollosa A, Ten Berge J, Atan D, Dick AD, De Boer JH, Kuiper J, Rothova A, Martín J.

J Med Genet. 2017 Jan;54(1):38-46. doi: 10.1136/jmedgenet-2016-104144. Epub 2016 Sep 8.

PMID:
27609017
18.

SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS.

Fonollosa A, Llorenç V, Artaraz J, Jimenez B, Ruiz-Arruza I, Agirrebengoa K, Cordero-Coma M, Costales-Mier F, Adan A.

Retina. 2016 Sep;36(9):1778-85. doi: 10.1097/IAE.0000000000001001.

PMID:
27183031
19.

In Response to: "Deuter CM, Zierhut M, Igney-Oertel A, et al. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment".

Mesquida M, Llorenç V, Adán A.

Ocul Immunol Inflamm. 2017 Apr;25(2):221-222. doi: 10.3109/09273948.2016.1145240. Epub 2016 Mar 25. No abstract available.

PMID:
27014943
20.

Interleukin-22 serum levels are elevated in active scleritis.

Sainz-de-la-Maza M, Molins B, Mesquida M, Llorenç V, Zarranz-Ventura J, Sala-Puigdollers A, Matas J, Adan A, Foster CS.

Acta Ophthalmol. 2016 Sep;94(6):e395-9. doi: 10.1111/aos.13005. Epub 2016 Mar 24.

Supplemental Content

Loading ...
Support Center